Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
11 Jan - 29 Mar 1988
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions
Remarks:
Comparable to guideline study with acceptable restrictions (no TA102 or E.coli. WP2 tester strain, only 2-Aminoanthracene was used as positive control with S9 mix). Also in accordance with GLP principles.
Cross-reference
Reason / purpose for cross-reference:
reference to same study
Reference
Endpoint:
in vitro DNA damage and/or repair study
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
11 Jan - 29 Mar 1988
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Remarks:
Also in accordance with GLP principles
Reason / purpose for cross-reference:
reference to same study
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 480 (Genetic Toxicology: Saccharomyces cerevisiae, Gene Mutation Assay)
Deviations:
no
GLP compliance:
yes
Type of assay:
mitotic recombination assay with Saccharomyces cerevisiae
Target gene:
enzyme of adenine metabolizing pathway
Species / strain / cell type:
yeast, other: Saccharomyces Cerevisiae D3
Additional strain / cell type characteristics:
not applicable
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254
Test concentrations with justification for top dose:
0.05, 0.1, 0.5, 1.0, 2.5% (w/v)
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: SMC (Sterigmatocystin, 0.005% (w/v), +S9); 1,2,3,4-Diepoxybutane (DEB, 0.025% (w/v), -S9)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium then plating on agar

DURATION
- Preincubation period: 4 hours
- Exposure duration: 3 days at 30°C, 1 day at 4°C

NUMBER OF REPLICATIONS: triplicates (1E-05 dilution) and quintuplicates (1E-03 dilution)

DETERMINATION OF CYTOTOXICITY
- Method: survival rate

Evaluation criteria:
Positive: A positive response in this assay is indicated by a dose-related increase of more than threefold in the absolute number of mitotic recombinants per milliliter and in the relative number of mitotic recombinants per 1.0E+05.
Negative: When no reproducible recombinogenic activity is obtained in any of the assays perfomred, the test results are considered to be negative.
Inconcluisve: When a test article cannot be identified clearly as causing a positive or negative response, the results are classified as inconclusive.
Species / strain:
Saccharomyces cerevisiae
Remarks:
D3
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
RANGE-FINDING/SCREENING STUDIES: A preliminary assay with dose levels of 0.01, 0.1, and 1% in the presence and absence of metabolic activation was done, no toxicity was seen.

Table 1: Results of Experiment I

 compound  S9 (%)  Conc. (%) (w/v)  Surviving cells/mL (x 10-7)  Survivors (%)  Mitotic Recombinants/mL (x 10-3) Mitotic Recombinants per 105 survivors
 DMSO  0    8.4  100  14  17
   10    7.6  100  8.0  11
 DEB  0  0.025  7.6  90  1100  1400
 SMC  0  0.005  8.2  98  8.0  9.8
   10  0.005  7.7  100  240  310
 Test substance  0  0.05  7.8  93  7.0 9.0 
   0  0.1  8.1  96  10  12
   0  0.5  7.7  92  12  16
   0  1.0  8.6  100  9.0  10
   0  2.5  7.7  92  10  13
   10  0.05  10.3  100  12  12
   10  0.1  9.7  100  9.0 9.3
   10  0.5  9.2  100  9.0  9.7
   10  1.0  8.5  100  8.0  9.4
   10  2.5  8.7  100  4.0  4.6

Table 2: Results of Experiment II

 compound  S9 (%)  Conc. (%) (w/v)  Surviving cells/mL (x 10-7)  Survivors (%)  Mitotic Recombinants/mL (x 10-3) Mitotic Recombinants per 105survivors
 DMSO  0    5.8  100  8.0  14
   10    5.3  100  9.0  17
 DEB  0  0.025  6.0  100  720  1200
 SMC  0  0.005  4.8  83  14  29
   10  0.005  6.9  100  130  190
 Test substance  0  0.05  6.4  100  10 16 
   0  0.1  5.3  91  13  24
   0  0.5  4.6  79  6.0  13
   0  1.0  5.5  95  12  22
   0  2.5  5.5  95  8.0  14
   10  0.05  7.3  100  20  27
   10  0.1  5.0  94  10 20
   10  0.5  6.4  100  5.0  7.8
   10  1.0  5.7  100  12  21
   10  2.5 6.6  100  12  18
Conclusions:
Interpretation of results: negative
The test material was not detected as being recombinogenic in the yeast Saccharomyces cerevisiae D3 assay with and without metabolic activation.
Executive summary:

The test material was tested for recombinogenic activity in the yeast Saccharomyces cerevisiae D3 assay for mitotic recombination. A preliminary assay was conducted at dose levles of 0.01, 0.1 and 1.0% in the presence and absence of metabolic activation. No toxicity was seen. Based on these results and on the solubility limitations of the compound, the two assays were performed at dose levels from 0.05 through 2.5% both in the presence and absence of 10% metabolic activation.

In the first assay, a slight increase, not dose-related, occurred in the number of mitotic recombinants, both with and without metabolic activation. Because these increases were slight, not dose-related, and not reproducible, they were not attributed to recombinogenic activity.

Therefore, the test material was not detected as being recombinogenic in the yeast Saccharomyces cerevisiae D3 assay with and without metabolic activation.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report date:
1988

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
yes
Remarks:
no TA102 or E.coli. WP2 tester strain, only 2-Aminoanthracene was used as positive control with S9 mix
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)
EC Number:
407-560-9
EC Name:
4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)
Cas Number:
107934-68-9
Molecular formula:
C25H18Cl2N2
IUPAC Name:
4-[9-(4-amino-3-chlorophenyl)-9H-fluoren-9-yl]-2-chloroaniline
Test material form:
solid: particulate/powder

Method

Target gene:
his operon
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
S. typhimurium TA 1538
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254
Test concentrations with justification for top dose:
preliminary assay: 10, 50, 100, 500, 1000, 5000 µg/plate (with and without metabolic activation)
experiment I: 10, 50, 100, 500, 1000, 5000 µg/plate (with and without metabolic activation)
experiment II: 5, 10, 50, 100, 500, 1000 µg/plate (with and without metabolic activation)
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
2-nitrofluorene
sodium azide
other: 2-Aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)

DURATION
- Exposure duration: 48 hours

NUMBER OF REPLICATIONS: triplicates each in 2 independent experiments

DETERMINATION OF CYTOTOXICITY
- Method: reduced background lawn, reduced number of colonies; formation of pinpoint colonies

Evaluation criteria:
Positive: A test article is considered a mutagen when it produces a reproducible, dose-related increase in the number of revertants in one or more strains. This increase should occur for at least three dose levels.
Negative: A test article is considered a nonmutagen when no dose-related increase in the number of revertants is observed in at least two independent experiments. The highest dose level tested for nontoxic solid substances and pure liquids is usually 5000µg/plate. For toxic compounds only the highest dose level tested should show evidence of toxicity.
Inconclusive: When a test article cannot be identified clearly as a mutagen or a nonmutagen in the assay, the results are classified as inconclusive.
Statistics:
No statistical analysis was performed.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Remarks:
Cytotoxicity only for TA1537 without metabolic activation in the first experiment at 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1538
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: precipitation was seen from 500µg/plate and upwards, for 1000 and 5000 µg/plate it interfered with counting of colonies wherefore plates were handcounted at those concentrations

RANGE-FINDING/SCREENING STUDIES: TA100 was used to screen for toxicity induced by the test article, with (4% v/v) and without metabolic activation, since no toxicity was seen the main experiments were carried out with 10% v/v S9 mix for metabolic activation.

Any other information on results incl. tables

Table 1: Results of Experiment I

 with or without S9 mix  Test substance concentration  Mean number of revertant colonies per plate (average of 3 plates  ± SD)            
    [µg/plate]  Base-pair substitution type     Frameshift type      
     TA100  TA1535  TA98  TA1537  TA1538
 -  0  119 ± 15  17 ± 9  17 ± 5  6 ± 1  18 ± 3
 -  10  114 ± 1  16 ± 3  20 ± 5 7 ± 2  12 ± 3
 -  50  114 ± 14  10 ± 1  24 ± 4  4 ± 1  14 ± 3
 -  100  104 ± 6  15 ± 1  19 ± 4  6 ± 1  6 ± 1
 -  500 P  92 ± 17  14 ± 8  15 ± 2  5 ± 3  9 ± 5
 -  1000 P  103 ± 15  13 ± 4  17 ± 6  8 ± 3  15 ± 5
 -  5000 P  125 ± 13  11 ± 3  15 ± 7 N  5 ± 1 T  17 ± 6
 positive control, -S9  Name  9-AA  SA  NF  9-AA  NF
   Conc. [µg/plate]  1  1  5  50  5
   Mean number of colonies/plate  457 ± 30  448 ± 9  1107 ± 80  571 ± 215  1503 ± 105
             
     TA100  TA1535  TA98  TA1537  TA1538
   0  153 ± 3  13 ± 1  34 ± 5  8 ± 2  32 ± 4
   10  137 ± 11  11 ± 11  42 ± 6  8 ± 4  39 ± 4
   50  134 ± 8  16 ± 7  42 ± 2  8 ± 1  32 ± 4
   100  175 ± 16  14 ± 1  42 ± 8  7 ± 3  28 ± 3
   500 P  162 ± 16  16 ± 3  41 ± 10  7 ± 3  25 ± 2
   1000 P  159 ± 10  11 ± 3  34 ± 4 N  9 ± 6  27 ± 7
   5000 P  132 ± 14 N  9 ± 3 N  39 ± 11 N  10 ± 4 N  30 ± 9 N
 positive control, +S9  Name  2 -AA   2 -AA   2 -AA   2 -AA   2 -AA
   Conc. [µg/plate]  1  2.5  1  2.5  1
   Mean number of colonies/plate 489 ± 64  158 ± 45  200 ± 16  68 ± 12

 178 ± 5

P = Precipitated

N = Normal background lawn

T = Thinning of background bacterial lawn, indicating toxicity

9 -AA = 9 -Aminoacridine

SA = Sodium Azide

NF = 2 -Nitrofluorene

2 -AA = 2 -Aminoanthracene

Table 2: Results of Experiment II

 with or without S9 mix  Test substance concentration  Mean number of revertant colonies per plate (average of 3 plates ±SD)            
    [µg/plate]  Base-pair substitution type     Frameshift type      
     TA100  TA1535  TA98  TA1537  TA1538
 -  0  114 ± 21  10 ± 4  14 ± 1  6 ± 2  14 ± 6
 -  5  125 ± 30  20 ± 5  21 ± 11  10 ± 1  15 ± 1
 -  10  130 ± 10  17 ± 2  19 ± 6  7 ± 2  13 ± 3
 -  50  133 ± 7  14 ± 1  19 ± 3  7 ± 3  14 ± 1
 -  100  128 ± 22  15 ± 6  19 ± 4  7 ± 3  13 ± 5
 -  500 P  121 ± 6  12 ± 2  18 ± 7  8 ± 2  11 ± 2
 -  1000 P  110 ± 11  10 ± 3  14 ± 3  5 ± 3  11 ± 3
 positive control, -S9  Name  9-AA  SA  NF  9-AA  NF
   Conc. [µg/plate]  1  1  5  50  5
   Mean number of colonies/plate  344 ± 22  207 ± 9  944 ± 49  414 ± 81  1060 ± 53
             
     TA100  TA1535  TA98  TA1537  TA1538
   0  142 ± 6  9 ± 3  37 ± 6  8 ± 1  29 ± 8
   5  164 ± 15  12 ± 3  37 ± 2  7 ± 3  35 ± 4
   10  156 ± 22  8 ± 2  35 ± 5  8 ± 1  27 ± 1
   50  137 ± 6  7 ± 5  35 ± 7  11 ± 2  25 ± 5
   100  146 ± 6  9 ± 2  39 ± 1  6 ± 1  22 ± 5
   500 P  144 ± 7  10 ± 3  32 ± 4  9 ± 2  27 ± 7
   1000 P  115 ± 1  8 ± 6  28 ± 16  5 ± 1  27 ± 9
 positive control, +S9  Name  2 -AA   2 -AA   2 -AA   2 -AA   2 -AA
   Conc. [µg/plate]  1  2.5  1  2.5  1
   Mean number of colonies/plate  745 ± 56  123 ± 8  660 ± 14  173 ± 41

 623 ± 13

P = Precipitated

N = Normal background lawn

T = Thinning of background bacterial lawn, indicating toxicity

9 -AA = 9 -Aminoacridine

SA = Sodium Azide

NF = 2 -Nitrofluorene

2 -AA = 2 -Aminoanthracene

Applicant's summary and conclusion

Conclusions:
Interpretation of results: negative
The test material was not detected as being mutagenic with or without metabolic activation in the standard Ames Salmonella/microsome assay with strains TA1535, TA1537, TA1538, TA98 and TA100 of the bacterium Salmonella typhimurium.
Executive summary:

The mutagenic activity of the test material in the Ames Salmonella/microsome assay was evaluated with a method similar to OECD TG 471 with strains TA1535, TA1537, TA1538, TA98 and TA100 of the bacterium Salmonella typhimurium and under GLP conditions.


The test material did not induce a significant dose-related increase in the number of revertant (His+) colonies in each of the five S. typhimurium tester strains (TA1538, TA1535, TA1537, TA98 and TA100) both in the absence and presence of S9-metabolic activation.  


In this study, the positive and solvent control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.


Based on the results of this study it is concluded that the test material is not mutagenic in the Salmonella typhimurium reverse mutation assay.